Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Brookfield Residential Properties Turns To Profit In Q1 - Quick Facts

RELATED NEWS
Trade BRP now with 

Canada-based Brookfield Residential Properties Inc. (BRP: Quote,BRP.TO: Quote) posted first-quarter net income attributable to the company of $1 million, or $0.01 per share, compared to a net loss of $56.98 million, or $0.56 per share in the previous year period. The first quarter of 2011 included a one-time valuation allowance against the Company's U.S. deferred tax assets on the completion of the merger.

Quarterly revenues declined to $132.15 million from $180.13 million in the comparable quarter last year. For the quarter, housing revenues increased to $88 million from $83 million, as a result of increased home closings.

Click here to receive FREE breaking news email alerts for Brookfield Residential Properties Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.